MedTrace Logo

Cardiac Magnetic Resonance Assessment for Heart Failure With Preserved Ejection Fraction

NCT04063579 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 172

Last updated 2023-05-10

No results posted yet for this study

Summary

This is a prospective study that aims to define the utility of cardiac magnetic resonance feature tracking (CMR-FT) as a non-invasive quantification tool to assess diastolic functionality in patients with Heart Failure with preserved ejection fraction.

Conditions

Interventions

DIAGNOSTIC_TEST

Cardiac Magnetic Resonance, Echocardiogram, Blood investigation (NT-proBNP), cardiac catheterization

Imaging, blood tests, LV pressure measurement

DIAGNOSTIC_TEST

Cardiac Magnetic Resonance, Echocardiogram, Blood investigation (NT-proBNP)

Imaging and Blood tests

Sponsors & Collaborators

  • The University of Hong Kong

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2021-09-29
Completion
2021-12-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04063579 on ClinicalTrials.gov